In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

GluMetrics closes $20.1mm Series C round

Executive Summary

GluMetrics (developing a glucose monitoring device for hospital use) raised $20.1mm in its Series C financing led by first-time backer New Leaf Venture Partners, which was joined by other new investor Kaiser Permanente Ventures and returning shareholders Advanced Technology Ventures and Versant Ventures.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register